NOVONIX (NVX) director holds 195,938 share rights exercisable by 2027

Rhea-AI Filing Summary

NOVONIX Ltd director Burrow Sharan reported a holding of 195,938 share rights linked to ordinary shares. These rights have a zero exercise price and are scheduled to become exercisable on December 31, 2026, with an expiration date of December 31, 2027. The filing reflects a position update rather than a new buy or sell transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Burrow Sharan

Role null

Type	Security	Shares	Price	Value
holding	Share rights	--	--	--

Holdings After Transaction: Share rights — 195,938 shares (Direct, null)

Footnotes (1)

Key Figures

Share rights underlying shares: 195,938 shares Exercise price: $0.0000 per share Exercisable date: December 31, 2026 +1 more

4 metrics

Share rights underlying shares 195,938 shares Underlying ordinary shares for reported share rights

Exercise price $0.0000 per share Exercise price of NOVONIX share rights

Exercisable date December 31, 2026 Share rights first exercisable date

Expiration date December 31, 2027 Share rights expiration

Key Terms

Share rights, Ordinary shares, exercise price, expiration date

4 terms

Share rights financial

"security_title: "Share rights" and derivativeSummary "Share rights""

Ordinary shares financial

"underlying_security_title: "Ordinary shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"conversion_or_exercise_price: "0.0000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2027-12-31T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burrow Sharan

(Last) (First) (Middle)

1029 WEST 19TH STREET

(Street)

CHATTANOOGA TENNESSEE 37408

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NOVONIX Ltd [ NVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share rights	$0							12/31/2026	12/31/2027	Ordinary shares	195,938		195,938	D

Explanation of Responses:

	Suzanne Yeates	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did NOVONIX (NVX) director Burrow Sharan report in this Form 4?

Director Burrow Sharan reported holding 195,938 share rights tied to NOVONIX ordinary shares. The entry reflects a holdings position, not an open-market buy or sell, and updates the disclosed equity exposure.

How many NOVONIX (NVX) share rights does Burrow Sharan hold?

The filing shows 195,938 share rights held directly by Burrow Sharan. Each right relates to NOVONIX ordinary shares, providing potential future equity exposure if the rights are exercised according to their terms and timelines.

What is the exercise price of Burrow Sharan’s NOVONIX share rights?

The share rights have an exercise price of $0.0000 per underlying ordinary share. This means no cash payment is required at exercise under the terms disclosed, subject to the vesting and timing conditions in the award.

When do Burrow Sharan’s NOVONIX share rights become exercisable and expire?

The share rights become exercisable on December 31, 2026 and expire on December 31, 2027. This one-year window defines when the rights can be converted into ordinary shares under the disclosed terms.

Does this NOVONIX Form 4 show any insider buying or selling?

The Form 4 records a holding entry with an unknown transaction code and no reported share purchases or sales. It primarily updates the disclosed balance of share rights rather than documenting an open-market trade.